Glucagon-like peptide-1 receptor agonists and their effects on weight reduction

被引：6

作者：

Shin, Shyi-Jang ^{[1
,2
]}

机构：

[1] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Kaohsiung, Taiwan

[2] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan

来源：

JOURNAL OF DIABETES INVESTIGATION | 2012年 / 3卷 / 06期

关键词：

D O I：

10.1111/j.2040-1124.2012.00241.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：490 / 491

页数：2

共 5 条

[1] Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients [J].

Eeg-Olofsson, K. ;

Cederholm, J. ;

Nilsson, P. M. ;

Zethelius, B. ;

Nunez, L. ;

Gudbjoernsdottir, S. ;

Eliasson, B. .

DIABETOLOGIA, 2009, 52 (01) :65-73

[2]

Izucchi SE, 2012, DIABETES CARE, V35, P1365

[3] The Impact of Frequent and Unrecognized Hypoglycemia on Mortality in the ACCORD Study [J].

Seaquist, Elizabeth R. ;

Miller, Michael E. ;

Bonds, Denise E. ;

Feinglos, Mark ;

Goff, David C., Jr. ;

Peterson, Kevin ;

Senior, Peter .

DIABETES CARE, 2012, 35 (02) :409-414

[4] Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials [J].

Vilsboll, Tina ;

Christensen, Mikkel ;

Junker, Anders E. ;

Knop, Filip K. ;

Gluud, Lise Lotte .

BMJ-BRITISH MEDICAL JOURNAL, 2012, 344

[5]

WHO, 2016, Obesity and overweight

← 1 →